PAEP and ovarian cancer: We show that whilst 5 of the markers significantly discriminate ovarian cancer cases from controls at the point of last measurement prior to diagnosis, only 3 (CA125, glycodelin, and HE4) demonstrate potential for earlier diagnosis.